Qiuhui Li

864 total citations
26 papers, 508 citations indexed

About

Qiuhui Li is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qiuhui Li has authored 26 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Pathology and Forensic Medicine and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qiuhui Li's work include Lymphoma Diagnosis and Treatment (14 papers), Cancer Cells and Metastasis (6 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Qiuhui Li is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Cancer Cells and Metastasis (6 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Qiuhui Li collaborates with scholars based in China, United States and Brazil. Qiuhui Li's co-authors include Dean G. Tang, Xin Chen, Kiera Rycaj, Liling Zhang, Fang Zhu, Xin Liu, Hsueh‐Ping Chao, Jianjun Shen, Collene Jeter and Bigang Liu and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Frontiers in Immunology.

In The Last Decade

Qiuhui Li

24 papers receiving 507 citations

Peers

Qiuhui Li
Pina Ziranu Italy
Muhammad Alamgeer Australia
Pietro Parcesepe Italy
Yanjie You China
Lingmi Hou China
Kelly E. Craven United States
Catherine J. Kennedy Australia
Céline Clémenson France
Daniel R. Zweitzig United States
Shuo You China
Pina Ziranu Italy
Qiuhui Li
Citations per year, relative to Qiuhui Li Qiuhui Li (= 1×) peers Pina Ziranu

Countries citing papers authored by Qiuhui Li

Since Specialization
Citations

This map shows the geographic impact of Qiuhui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuhui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuhui Li more than expected).

Fields of papers citing papers by Qiuhui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiuhui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuhui Li. The network helps show where Qiuhui Li may publish in the future.

Co-authorship network of co-authors of Qiuhui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qiuhui Li. A scholar is included among the top collaborators of Qiuhui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuhui Li. Qiuhui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Kewei, Xin Zheng, Tao Liu, et al.. (2024). Tissue-Matched IgH Gene Rearrangement of Circulating Tumor DNA Shows Significant Value in Predicting the Progression of Diffuse Large B Cell Lymphoma. The Oncologist. 29(5). e672–e680. 3 indexed citations
2.
Zhao, Kewei, et al.. (2024). Identification of oxidative stress-related hub genes for predicting prognosis in diffuse large B-cell lymphoma. Gene. 935. 149077–149077. 2 indexed citations
3.
Zhao, Kewei, et al.. (2024). Single-cell transcriptome sequencing provides insight into multiple chemotherapy resistance in a patient with refractory DLBCL: a case report. Frontiers in Immunology. 15. 1303310–1303310. 2 indexed citations
4.
Li, Xinyi, Danju Luo, Liling Zhang, et al.. (2023). Accurate interpretation of p53 immunohistochemical patterns is a surrogate biomarker for TP53 alterations in large B-cell lymphoma. BMC Cancer. 23(1). 1008–1008. 2 indexed citations
5.
Li, Xiaoqian, Qiuhui Li, Fang Zhu, et al.. (2023). A new prognostic nomogram in patients with mucosa-associated lymphoid tissue lymphoma: a multicenter retrospective study. Frontiers in Oncology. 13. 1123469–1123469. 2 indexed citations
6.
Li, Qilin, Wei‐Min Chen, Qiuhui Li, Jing Mao, & Xin Chen. (2022). A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma. Frontiers in Immunology. 13. 1019967–1019967. 37 indexed citations
7.
Liu, Zijian, Qiuhui Li, Tao Liu, et al.. (2021). Case Report: Long-Term Response to Radiotherapy Combined With Targeted Therapy in Histiocytic Sarcoma Harboring Mutations in MAPK and PI3K/AKT Pathways. Frontiers in Oncology. 11. 755893–755893. 3 indexed citations
8.
Li, Qiuhui, et al.. (2021). Synchronous double primary lymphoma and thyroid cancer. Medicine. 100(39). e27061–e27061. 6 indexed citations
9.
Zhu, Fang, Qiuhui Li, Huaxiong Pan, et al.. (2020). Successful Treatment of Chidamide and Cyclosporine for Refractory/Relapsed Angioimmunoblastic T Cell Lymphoma With Evans Syndrome: A Case Report With Long-Term Follow-Up. Frontiers in Oncology. 10. 1725–1725. 1 indexed citations
10.
Li, Qiuhui, et al.. (2020). A Primary Mediastinal Large B-Cell Lymphoma Patient With COVID-19 Infection After Intensive Immunochemotherapy: A Case Report. Frontiers in Oncology. 10. 924–924. 11 indexed citations
11.
Meng, Jingshu, Huaxiong Pan, Xiaoqian Li, et al.. (2019). Diagnosis and Treatment of Synchronous Lymphoma and Digestive System Carcinoma: Report of Four Cases and Literature Review. Frontiers in Oncology. 9. 1367–1367. 11 indexed citations
12.
Zhu, Fang, Tao Liu, Qiuhui Li, et al.. (2019). Beneficial effect of consolidative radiotherapy for patients with lymphoma and skeletal involvement. Medicine. 98(31). e16688–e16688. 3 indexed citations
13.
Liu, Tao, Fang Zhu, Qiuhui Li, et al.. (2018). Pegaspargase, gemcitabine, dexamethasone, and cisplatin (P-GDP) combined chemotherapy is effective for newly diagnosed extranodal NK/T-cell lymphoma: a retrospective study. Cancer Management and Research. Volume 10. 5061–5069. 7 indexed citations
14.
Chen, Xin, Qiuhui Li, Xin Liu, et al.. (2016). Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer. Clinical Cancer Research. 22(17). 4505–4516. 75 indexed citations
15.
Jeter, Collene, Bigang Liu, Yue Lu, et al.. (2016). NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis. Cell Discovery. 2(1). 16041–16041. 42 indexed citations
16.
17.
Liu, Xin, Xin Chen, Kiera Rycaj, et al.. (2015). Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells. Oncotarget. 6(27). 23959–23986. 58 indexed citations
18.
Wu, Gang, Qiuhui Li, Jing Chen, et al.. (2015). NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOR phosphorylation. OncoTargets and Therapy. 8. 269–269. 24 indexed citations
19.
Wu, Gang, Chan Fong Chang, Fang Zhu, et al.. (2015). Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway. Oncotarget. 6(38). 40907–40919. 79 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pina Ziranu Breakdown of academic impact, for papers by Muhammad Alamgeer Breakdown of academic impact, for papers by Pietro Parcesepe Breakdown of academic impact, for papers by Yanjie You Breakdown of academic impact, for papers by Lingmi Hou Breakdown of academic impact, for papers by Kelly E. Craven Breakdown of academic impact, for papers by Catherine J. Kennedy Breakdown of academic impact, for papers by Céline Clémenson Breakdown of academic impact, for papers by Daniel R. Zweitzig Breakdown of academic impact, for papers by Shuo You
Rankless by CCL
2026